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Background:Manual disinfection of medical devices is prone to failure. Disinfection by aerosolized hydrogen
peroxide might be a promising adjunctive method. We aimed to assess effectiveness of dry mist of hydrogen
peroxide (HPDM) on noncritical medical equipment.
Methods: One cycle of HPDM was applied on a convenience sample of 16 different types of ''ready to use''
noncritical medical devices in a closed, but nonsealed room. Of every object, 2 adjacent areas with assumed
similar bacterial burden were swabbed before and after HPDM deployment, respectively. After culturing, col-
ony forming units (CFU) were counted, and bacterial burden per cm2 calculated.
Results: Of 160 objects included in the study, 36 (23%) showed a CFU-count of zero both before and after
HPDM use. A decrease from a median of 0.14 CFU/cm2 (range: 0.00-125.00/cm2) to a median of 0.00 CFU/cm2
(range: 0.00-4.00/cm2) (P < .001) was observed. The bacterial burden was reduced by more than 90% in 45%
(95% CI: 37-53) of objects. No pathogenic bacteria were identified.
Discussion: HPDM reduced bacterial burden on noncritical medical items. Since cleanliness of the included
''ready to use'' objects was high and no pathogens were found before nebulization, the HPDM device did not
increase patient safety in this setting.
Conclusion: HPDM nebulization can be a useful nonmanual adjunctive disinfection method in high-risk settings.
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Hospitalized patients are at constant risk of acquiring multidrug
resistant organisms (MDRO) or developing healthcare-associated
infections. Many studies have demonstrated that environmental sur-
faces (eg, bedrails) and equipment (eg, stethoscopes) are a reservoir
for pathogenic bacteria including MDRO.1-6 In a comprehensive
review, Otter et al. summarize evidence that contaminated surfaces
contribute to the transmission of hospital pathogens.7 It was also
shown that patients who are admitted to a room previously occupied
by a patient colonized or infected with vancomycin-resistant entero-
cocci (VRE), methicillin-resistant Staphylococcus aureus (MRSA) or
other pathogenic bacteria, are at increased risk of acquiring this spe-
cific pathogen from the previous patient.8-11 To reduce bacterial bur-
den of surfaces and equipment, effective cleaning and disinfection is
required.
Disinfection describes a process that eliminates many or all patho-
genic microorganisms, except bacterial spores, on inanimate
objects.12 Noncritical items—items that come in contact with intact
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skin but not mucous membranes—such as medical equipment (eg,
bedpans, blood pressure cuffs, crutches) and environmental surfaces
(eg, bedside tables) are disinfected with a low-level disinfectant.12
However, disinfection procedures are highly operator-dependent
and prone to failure when executed manually.13 Therefore, nonman-
ual automatized disinfection techniques, such as aerosolized hydro-
gen peroxide (HP) or ultraviolet light, are an interesting alternative
or adjunctive infection control measure.
Airborne HP is active against a wide range of microorganisms,
including bacteria, yeasts, fungi, viruses, and spores. It can either be
applied in aerosolized (eg, dry mist) or vaporised form. Passaretti
et al. showed that the risk of acquiring an MDRO in general, and a
VRE specifically, was reduced by 64% and 80%, respectively after
room disinfection with HP.14 Horn et al. demonstrated that the odds
ratios of acquiring an extended-spectrum beta-lactamase producing
Gram-negative bacterium, an MRSA, a VRE, and Clostridium difficile
after introducing HP vapour for terminal decontamination of patient
rooms were 0.06, 0.53, 0.05, and 0.65, respectively.15
Medical equipment, which is commonly removed from the
patient room before terminal room disinfection, was shown to be
often contaminated by pathogens.1-5 It comes into direct contact
with the patient or is placed in the immediate patient environment.
Moreover, some parts of the medical equipment may be difficult to
disinfect manually. These items might therefore benefit from an
adjunctive, standardized, nonmanual disinfection step to further
reduce bacterial burden before being passed to the next patient.
With the present study, we aimed to investigate the effectiveness of
applying a single cycle of HP aerosolized disinfection of noncritical
medical items.
METHODS
Study setting and objects
The study was conducted at the University Hospital Zurich, Swit-
zerland, a 950-bed tertiary-care teaching hospital with 6 intensive
care units (ICU).
We included 16 different noncritical object types, 8 from general
wards and ICUs each. A convenience sample of noncritical objects
''ready to use,'' that is disinfected according to internal University
Hospital Zurich guidelines with aldehyd- (Kohrsolin FF) or alcohol
based (Meliseptol) disinfectants, were collected throughout the hos-
pital. Healthcare professionals (HCP) were not aware of the study
execution, and the routine disinfecting procedure had not been
supervised. Ten items of every object type were analysed.
Dry mist hydrogen peroxide nebulization procedure
A programmable device (HyperDRYMist, Modulator Micro-Neb-
ulizer 99MB by 99Technologies, Switzerland) generating a dry mist
of hydrogen peroxide, with a particle size of < 1 mm, was used. The
disinfecting solution consists of purified water, 6.6% w/w hydrogen
peroxide, 60 mg/l silver cations and a set of undisclosed proprietary
co-formulants, which synergistically enhance biocidal action. The
bactericidal properties result from the oxidative action of hydroxyl
radicals on the lipid membrane, DNA, and other essential cell compo-
nents of microorganisms, and the effect of silver cations that reverse
membrane polarity and inhibit protein synthesis and cytoplasmic
enzyme activity. The disinfectant is micro-nebulized as a dry aerosol
that accesses all surfaces exposed to air. Disinfection happened in a
nonclimatized room of 60 m3 with closed, but unsealed doors and
windows. The HPDM micro-nebulizer was placed in a corner of the
room, and the study objects were placed at a distance of >2 m from
the machine. One cycle consisted of 10 minutes ''dissemination time''
(ie, time of active nebulization), 45 minutes ''exposure time'' (ie, time
of ongoing activity and progressive decay of hydrogen peroxide), and
15 minutes ''ventilation time'' (ie, time of clearing residue levels of
hydrogen peroxide by ventilating the room). A total of 3 ml/m3 of dis-
infectant solution was nebulized, corresponding to 140 ppm of
hydrogen peroxide.
Sampling and microbiology
Swab samples of 160 objects were collected before and after neb-
ulization. Shape and dimension of swabbed area was individualized
according to object (Fig 1, and Appendix A). The largest possible area
making a rectangle or round shape was swabbed. Hypothesising that
swabbing removes bacteria, 2 adjacent areas with assumed equal
bacterial burdens (area A and B) were swabbed before and after neb-
ulization.
Sampling was performed with moistened eSwabs comprising 1
millilitre of Liquid Amies medium. Specimens were stored at 4°C and
processed within 24 hours after sampling. After vortexing the swabs
in Amies medium for 15 seconds, an aliquot of 500 ml Liquid Amies
medium per sampled object was plated on a 5% sheep blood agar
plate. The agar plates were incubated 72 hours at 36°C, and colony
forming units (CFU) of aerobic bacterial growth per agar plate were
counted manually.
Identification of both opportunistic and pathogenic bacteria (eg,
S. aureus, Enterobacteriaceae ssp., Pseudomonas aeruginosa, and
Enterococci ssp.), as well as environmental flora was performed by
experienced laboratory technicians in the on-site laboratory. After
culturing aerobic bacteria on sheep blood agar, subculturing was per-
formed on sheep blood and MacConkey agar. For species identifica-
tion catalase and oxidase test, followed by latex agglutination test for
S. aureus identification and multicolor system Enterotubes for identi-
fication of Enterobacteriaceae ssp. were used.
Bacterial burden
For samples with CFU too numerous to count, CFU count was set
to 500 per sampled area. Bacterial burden was calculated in CFU/cm2.
According to Dancer et al. we defined a “clean object” as an object
with <5 CFU/cm2.16
Fig 1. Example of study object. The swabbed area of all study objects was divided in
area A and area B of same size and hypothetically same bacterial burden. Areas A and B
were swabbed before and after nebulization alternately.
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The “percentage decrease” of CFU after nebulization was calcu-
lated as follows:





If bacterial burden before nebulization was zero any increase of
bacterial burden after nebulization was set as “percentage
decrease” =100%.
Categorization of objects
For subgroup analysis we grouped the objects according to: (1)
ward type, that is objects collected on general wards vs objects col-
lected on ICUs; (2) material, that is plastic, metal and fabric; (3) Flat,
“easy to clean” objects vs angled, nonflat “difficult to clean” objects
(Table 1).
Statistical analysis
Wilcoxon rank sum test was used to compare bacterial burdens
between objects. Wilcoxon signed ranks test was used for paired
comparison of bacterial burden before and after nebulization. After
dichotomizing results of percentage of decrease in ≥90% and <90%
(“90% decrease”), Fisher’s exact test was used to test for differences
between object types, materials, and bacterial burden before nebuli-
zation. Significance was set as P <.05. All statistical analyses were
performed with STATA version 15 (Stata Corp., College Station, TX).
RESULTS
Object type and bacterial burden before nebulization is shown in
Table 1. We found high median colonization on ECG electrodes,
patients’ phones, pulse oximeters and on remote controls, and low
median colonization on the inside of infusion pumps, monitors,
stethoscope diaphragms, and wheelchairs. Before nebulization, no
bacterial growth was detected in 25.6% of objects. Eight (5%) objects
were “not clean,” that is ≥5 CFU/cm2, according to Dancer et al.’s
''microbiological standards for surface hygiene in hospitals'' (2 ECG
electrodes, 2 patients’ phones, 2 pulse oximeters, 2 remote con-
trols).16 In all 124 objects with detectable colonization, only skin or
environmental flora was identified and no pathogenic bacterium was
found. For raw data of all sampled items see Appendix B.
Of all 160 objects, 23% (n = 36) did not show bacterial contamina-
tion before and after nebulization. Table 2 shows median bacterial
burden before and after nebulization, and median ''percentage
decrease'' due to nebulization. Fig 2 shows median CFU before and
after nebulization per object type, Appendix C shows results for
every single object. Across all objects, we found decrease from a
median of 0.14 CFU/cm2 (range: 0.00-125.00) to a median of 0.00
CFU/cm2 (range: 0.00-125.00, P < .001). All but 6 objects (insides of
infusion pump, stethoscope diaphragms, syringe pump, thermome-
ter, tourniquet, and wheelchairs) showed a statistically significant
CFU decrease. After nebulization, 99% (n = 159) of objects were
“clean,” according to Dancer’s “microbiological standards for surface
hygiene in hospitals” 16 and 63% (n = 100) showed no bacterial
growth. In 45% of objects (95% confidence interval (CI): 37-53) the
decrease of CFU was more than 90%.
Before nebulization, objects from general wards had higher CFU
counts compared to objects from ICUs (median 0.10 CFU/cm2 [range:
0.00-4.00] vs 0.29 CFU/cm2 [0.00-14.2; P =.033]). Nebulization of
objects from general wards and ICUs lead to a “90% decrease” in 35%
(CI: 25-46) and 55% (CI: 43-66; P =.033), respectively. We did not find
differences in nebulization effectiveness when comparing objects of
different materials, nor when comparing “difficult to clean” and
“easy to clean” objects (data not shown). In “nonclean” objects with a
bacterial burden > 5 CFU/cm2 (n = 8), the HPDM nebulization resulted
in a median decrease of 89% CFU (data not shown)
DISCUSSION
Our study, investigating a nonmanual disinfection method of non-
critical medical equipment, demonstrated that 23% of the objects
''ready to use'' did not show any bacterial contamination and 95%
were ''clean'' (ie, <5 CFU/cm2) before HPDM nebulization. Further-
more, including all objects into analysis, HPDM led to a median CFU
decrease of 79% (IQR: 0-100) and reduced more than 90% of CFU in
45% (72/160) of objects.
The objects of noncritical medical equipment included in our
study were ''ready to use'' and showed a low bacterial burden. Com-
pared to other studies assessing contamination after standard
Table 1
Bacterial burden of all objects before nebulization






Material “Easy to clean” vs
“Difficult to clean”




Blood pressure cuff 10 285 GW P E 0.22 (0.01-0.73) .614
ECG electrodes 10 35 GW M D 1.23 (0.00-14.29) .001
Infusion pump (inside) 10 108 ICU M D 0.01 (0.00-0.11) .004
Infusion pump (outside) 10 54 ICU P E 0.13 (0.00-0.67) .631
Infusion stand 10 145 GW M E 0.04 (0.00-0.40) .079
Monitor 10 127 ICU P E 0.01 (0.00-0.13) .003
Oxygen regulator 10 20 ICU P E 0.20 (0.00-0.70) .865
Patient’s phone 10 8 GW P E 1.50 (0.00-8.50) .001
Pulse oximeter 10 4 ICU P D 1.00 (0.00-125.00) .014
Remote control 10 50 GW P E 1.68 (0.04-10.00) .003
Stethoscope diaphragm 10 8 GW P E 0.00 (0.00-4.00) .021
Suction pump 10 22 ICU P E 0.27 (0.09-3.82) .076
Syringe pump 10 93 ICU P D 0.03 (0.00-0.47) .107
Thermometer 10 8 ICU P D 0.25 (0.00-0.50) .382
Tourniquet 10 52 GW F D 0.42 (0.00-1.88) .126
Wheelchair 10 108 GW M E 0.00 (0.00-1.13) .001
All objects 160 0.14 (0.00-125.00)
NOTE. Baseline bacterial burden (CFU/cm2) of all 160 objects before HPDM nebulization. CFU counts of samples with CFU too numerous to count were set to 500 CFU per sampled
area. CFU too numerous to count were present on 2 ECG electrodes, 2 pulse oximeters and 2 remote controls. * Wilcoxon rank-sum test was used to compare bacterial burden
between objects.
cm2, square centimetres; HPDM, hydrogen peroxide dry mist; D, “difficult to clean” object; E, “easy to clean” object; F, fabric; ICU, intensive care unit; GW, general ward; M, metal;
No., number; P, plastic
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disinfection procedures we found a 10-100 fold lower median bacte-
rial burden of only 0.14 CFU/cm2.17-19 Moreover, no pathogenic bac-
teria were identified on the included medical devices. Still, 8 out of
160 objects (5%) were ''not clean'' (ie, ≥5 CFU/cm2) according to
established criteria,16 even though all objects should have undergone
a disinfection procedure according to our hospitals’ guidelines. Heavy
contamination is a surrogate marker of an insufficient cleaning and
disinfection process and points out the critical role of the human fac-
tor in the cleaning procedure,20
We found that in 45% of objects HPDM nebulization led to a more
than 90% decrease in CFU. In heavily contaminated objects, the
HPDM nebulization resulted in a median decrease of 89% CFU. Other
studies also reported good effectiveness of HP systems. Weber et al.
reviewed the effectiveness of HP systems for terminal room decon-
tamination and found several studies (predominantly using vapor-
ized HP) demonstrating reduction of multidrug-resistant organisms
by a percentage between 86% and 100%.21 A systematic review by
Falagas et al. found that disinfection with terminal cleaning vs HP
reduced the percentage of contaminated environmental sites from
39% to 28.3% vs 2.2%, respectively.22 The studies included in these
2 reviews might not be entirely comparable to our study, as all but
1 study targeted pathogenic bacteria only (eg, MRSA, Serratia sp.)—in
Table 2
Bacterial burden of included objects before and after nebulization












Blood pressure cuff 10 0.22 (0.01-0.73) 0.06 (0.01-0.15) 69.88 (-55.56-94.23) 30 .014
ECG electrodes 10 1.23 (0.00-14.29) 0.14 (0.00-5.71) 85.79 (0.00-100.00) 30 .006
Infusion pump (inside) 10 0.01 (0.00-0.11) 0.00 (0.00-0.06) 0.00 (-100.00-100.00) 30 .499
Infusion pump (outside) 10 0.13 (0.00-0.67) 0.00 (0.00-0.15) 100.00 (0.00-100.00) 70 .008
Infusion stand 10 0.04 (0.00-0.40) 0.00 (0.00-0.03) 100.00 (0.00-100.00) 70 .008
Monitor 10 0.01 (0.00-0.13) 0.00 (0.00-0.02) 0.00 (0.00-100.00) 40 .047
Oxygen regulator 10 0.20 (0.00-0.70) 0.00 (0.00-0.20) 100.00 (0.00-100.00) 80 .007
Patient’s phone 10 1.50 (0.00-8.50) 0.25 (0.00-3.75) 82.64 (0.00-100.00) 40 .006
Pulse oximeter 10 1.00 (0.00-125.00) 0.00 (0.00-4.00) 100.00 (0.00-100.00) 80 .008
Remote control 10 1.68 (0.04-10.00) 0.46 (0-00-3.20) 64.58 (0.00-100.00) 20 .006
Stethoscope diaphragm 10 0.00 (0.00-4.00) 0.00 (0.00-0.00) 0.00 (0.00-100.00) 30 .084
Suction pump 10 0.27 (0.09-3.82) 0.09 (0.00-0.64) 81.67 (0.00-100.00) 40 .006
Syringe pump 10 0.03 (0.00-0.47) 0.01 (0.00-1.31) 34.09 (-1933.33-100.00) 40 .299
Thermometer 10 0.25 (0.00-0.50) 0.00 (0.00-0.25) 100.00 (-100.00-100.00) 60 .051
Tourniquet 10 0.42 (0.00-1.88) 0.08 (0.00-2.81) 28.79 (-563.64-100.00) 40 .575
Wheelchair 10 0.00 (0.00-1.13) 0.00 (0.00-0.00) 0.00 (0.00-100.00) 20 .158
NOTE. Bacterial burden before and after HPDM nebulization of objects * Wilcoxon signed ranks test compares bacterial burden (in CFU/ cm2) from objects before nebulization with
bacterial burden (in CFU/cm2) after nebulization.
CFU, colony forming unit; CI, confidence interval; cm2, square centimetres; ECG, electrocardiogram; No., number.
Fig 2. Median bacterial burden before and after nebulization. Median bacterial burden (CFU/cm2) before and after HPDM nebulization of objects. (CFU, colony forming unit; cm, cen-
timetre; ECG, electrocardiogram).
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our study, on the other hand, we did not find pathogenic bacteria on
any of our objects before the study procedure. Additionally, most of
the included studies in the aforementioned reviews used vaporisa-
tion systems, which were reported to be more effective than aerosol-
ized HP.23,24
The vast majority of previous studies evaluating HP effectiveness
investigated noncritical environmental surfaces and not medical
devices. We identified only a single study testing effectiveness of HP
disinfection on medical devices using Bacillus spores as indicators.25
This study especially assessed decontamination of the inner part of
medical equipment (ie, ventilators or suction pumps) and found that
3 diffusion cycles of HP dry aerosol had a sporicidal effect in 62% of
tested items, with an increase to 100% effectiveness when devices
were ventilated.
Compared to environmental surfaces, noncritical medical devices
might be more difficult to clean. In our study, many of the included
objects, eg. pulse oximeters, were angled and not flat. CFU decrease
did not differ between these probably ''difficult to clean'' objects
compared to ''easy to clean'' objects. One particular advantage of HP
disinfection is that all surfaces exposed to the HP-containing air are
disinfected irrespective of their shape. After expiration of the dissem-
ination time, the concentration of HP is evenly distributed in the
whole room and distance between object and HP device is negligible.
“Difficult to clean” objects might therefore benefit the most from this
nontouch disinfection technique.
Our study has limitations. First, we included “ready to use” medi-
cal devices and assumed prior disinfection according to our hospitals’
guidelines, but the execution of the disinfection procedure could not
be verified. This, however, better represents a real-life situation. Sec-
ond, we included 36 objects into the analysis of this real life study
that did neither show contamination before nor after nebulization.
That, in turn, has led to an underestimation of HPDM nebulization
efficacy. By performing a sensitivity analysis excluding these 36
objects, we found that the median percentage decrease was 100%
and the 90%-decrease was 58% (data not shown). Third, we did not
use neutralizers to inactivate residual disinfectants potentially inhib-
iting bacterial growth, thus potentially leading to an underestimation
of bacterial contamination before nebulization. Still, the relative
reduction of CFU count is unchanged, as aerosolized hydrogen perox-
ide does not require the use of neutralizers, as it breaks down into
water and oxygen relatively rapidly (within 30 minutes on a
surface).26
CONCLUSIONS
In conclusion, our study testing an easy-to-use HPDM device on
noncritical medical items in a “real life setting,” shows relevant reduc-
tion of bacterial burden after HP disinfection. Of interest, bacterial bur-
den before nebulization was very low in our hospital and we did only
identify nonpathogenic bacteria on the included objects. Thus, effec-
tiveness of the HPDM system to reduce pathogenic bacteria could not
be proven. Nevertheless, noncritical medical equipment has been
shown to be contaminated with pathogens in many other settings. The
effectiveness of HP systems to reduce contamination with MRSA, C. dif-
ficile and other pathogens was demonstrated by other authors and
there is no rationale to assume a different efficacy between pathogenic
and nonpathogenic bacteria.27-29 In view of the fact that medical devi-
ces can act as fomites, HPDM nebulization might act as “safety-net” in
disinfection processes on high-risk wards like ICUs or during out-
breaks. It could for example be used to routinely disinfect noncritical
medical equipment after patient discharge or during the patient’s
absence from the room due to a medical procedure. Alternatively, non-
critical medical equipment could be pooled in a small room allowing
an even shorter disinfection cycle time due to the low room volume.
Use of the present HPDM device exhibits less logistic issues compared
to vapour HP techniques as no room sealing is needed and room occu-
pation dead-time is usually less than 1 hour. Compatibility of HP disin-
fectants with medical equipment has to be assessed before application.
Further research is warranted to investigate if HPDM disinfection of
noncritical medical devices reduces MDRO transmission in routine use
within real-world settings.
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